Cargando…
Blocking leukotrienes optimize asthma control: The BLOC survey
OBJECTIVE: The aim of this study was to evaluate asthma control after the introduction of a leukotriene modifier (Montelukast), in addition to the current controller asthma therapies, in patients with inadequately controlled mild-to-moderate persistent asthma. Asthma control and patient perception w...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2732093/ https://www.ncbi.nlm.nih.gov/pubmed/19727354 http://dx.doi.org/10.4103/1817-1737.33696 |